Raiffeisen Switzerland Cooperative Share Price

Certificat

MOFRCH

CH1259332497

Market Closed - Swiss Exchange 16:20:01 01/07/2024 BST
100.8 CHF +0.12% Intraday chart for Raiffeisen Switzerland Cooperative
Current month+0.12%
3 months+1.20%
Date Price Change
01/07/24 100.8 +0.12%
28/06/24 100.6 +0.11%
27/06/24 100.5 +0.06%

Delayed Quote Swiss Exchange

Last update July 01, 2024 at 04:20 pm

More quotes

Static data

Product typesonstige Zertifikate
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Raiffeisen Switzerland B.V.
MOFRCH
ISINCH1259332497
Date issued 07/07/2023
Maturity 07/07/2025 (366 Days)
Parity 0.27 : 1
Emission price 100 CHF
Emission volume N/A
Settlement Beides
Currency CHF

Technical Indicators

Highest since issue 101.1 CHF
Lowest since issue 95.63 CHF
Spread 8.1 CHF
Spread %0.80%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
243.3 CHF
Average target price
276.6 CHF
Spread / Average Target
+13.70%
Consensus
  1. Stock Market
  2. Certificates
  3. MOFRCH Certificat